INFUSYSTEM HOLDINGS, INC Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
INFUSYSTEM HOLDINGS, INC (INFU) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of 0.00% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2026-02-27
- INFUSYSTEM HOLDINGS, INC effective income tax rate reconciliation, other adjustments, percent for fiscal 2025 was 0.00%.
- INFUSYSTEM HOLDINGS, INC effective income tax rate reconciliation, other adjustments, percent for fiscal 2024 was 0.00%.
- INFUSYSTEM HOLDINGS, INC effective income tax rate reconciliation, other adjustments, percent for fiscal 2021 was -8.50%, a 666.67% decline from fiscal 2020.
- INFUSYSTEM HOLDINGS, INC effective income tax rate reconciliation, other adjustments, percent for fiscal 2020 was 1.50%.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | 0.00% 10-K · filed 2026-02-27 | |
| 2024-12-31 | 0.00% 10-K · filed 2026-02-27 | |
| 2021-12-31 | -8.50% 10-K · filed 2022-03-15 | |
| 2020-12-31 | 1.50% 10-K · filed 2022-03-15 | |
| 2019-12-31 | -0.60% 10-K · filed 2022-03-15 | |
| 2018-12-31 | -0.10% 10-K · filed 2020-03-30 | |
| 2017-12-31 | 0.40% 10-K · filed 2019-03-22 | 0.37% 10-K · filed 2018-03-19 |
| 2016-12-31 | 0.31% 10-K · filed 2018-03-19 | |
| 2015-12-31 | 0.14% 10-K · filed 2017-03-22 | 0.46% 10-K · filed 2016-03-09 |
| 2014-12-31 | 2.96% 10-K/A · filed 2016-12-12 | |
| 2013-12-31 | 4.58% 10-K · filed 2015-03-09 | |
| 2012-12-31 | -0.48% 10-K · filed 2014-03-11 | |
| 2011-12-31 | 0.12% 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |